Establishment of the concept of androgen insensitivity syndrome due to the abnormality of transcriptional cofactor and analysis of the responsible cofactor.
转录辅助因子异常引起的雄激素不敏感综合征概念的建立及相关辅助因子的分析。
基本信息
- 批准号:10671037
- 负责人:
- 金额:$ 2.43万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We found a patient who was diagnosed phenotypically and endocrinologically as having complete androgen insensitivity syndrome (AIS), but who had no abnormality in the androgen receptor (AR) gene. Transactivation by the normal entire AR in the patient fibroblasts was markedly low compared with that in the controls, strongly suggesting that this patient manifests AIS due to the abnormality of coactivator. The aims of the present study were the establishment of the concept of a coactivator disease and the isolation of its coactivator, and the following results were obtained. Investigation of the transactivation by the AR, glucocorticoid receptor (GR), their AF-1- or AF-2-truncated receptors and their chimeric receptors in primary-cultured genital skin fibroblasts from the patient revealed that transmission of the activation signal from AF-1 of the AR was disrupted. Co-transfection of known transcriptional cofactors did not restore the impaired AR-dependent transactivation in the patient. The binding of a protein with an apparent Mr of about 90 kDa to GST-fused AF-1 of the AR was lost in the patient fibroblasts. A cDNA which enhances the AR-dependent transactivation was isolated by yeast two hybrid system using as AR-AF-1 as a bait.In conclusion, we have established a new form of steroid hormone insensitivity, a coactivator disease, and also isolated one of the AR-AF-1-specific coactivators.
我们发现了一名患者,他的表型和内分泌学诊断为完全雄激素不敏感综合征(AIS),但雄激素受体(AR)基因没有异常。与对照组相比,患者成纤维细胞中正常完整AR的反式激活显著降低,强烈提示该患者由于辅活化子的异常而表现为AIS。本研究的目的是建立共激活型疾病的概念并分离其共激活型疾病,并取得了以下结果。在原代培养的生殖器皮肤成纤维细胞中,对AR、糖皮质激素受体(GR)、其AF-1或AF-2截短受体及其嵌合受体反式激活的研究表明,AR的AF-1激活信号的传递被中断。共转染已知的转录辅因子不能恢复患者受损的AR依赖的反式激活。在患者成纤维细胞中,一个表观MR约为90 kDa的蛋白质与AR的GST融合的AF-1结合丢失。利用酵母双杂交系统,以AS AR-AF-1为诱饵,分离到一个增强AR依赖反式激活的基因,从而建立了一种新的类固醇激素不敏感型共激活剂病,并分离到一种AR-AF-1特异性辅激活剂。
项目成果
期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimoike T et al.: "Subcutaneous or visceral adipose tissue expression of the PPAR g gene is not altered in the fatty (fa/fa) Zucker Rat"Metabolism. 47. 1494-1498 (1998)
Shimoike T 等人:“皮下或内脏脂肪组织中 PPAR g 基因的表达在脂肪 (fa/fa) Zucker 大鼠中没有改变”代谢。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Natori S et al.: "Chromogranin B (secretogranin I), a neuroendocrine-regulated secretory protein, is sorted to exocrine secretory granules in transgenic mice"EMBO J. 17. 3277-3289 (1998)
Natori S 等人:“Chromogranin B (secretogranin I),一种神经内分泌调节的分泌蛋白,在转基因小鼠中被分类为外分泌分泌颗粒”EMBO J. 17. 3277-3289 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirase N et al.: "Thioazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL6O"Oncology. 57(suppl 2). 17-26 (1999)
Hirase N 等人:“噻唑烷二酮诱导早幼粒细胞白血病细胞系 HL6O 中的细胞凋亡和单核细胞分化”肿瘤学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohe K.: "Nicotinamide potentiates TSHR and MHC classII promoter activity in FRTL-5 cells"Mol. Cell. Endocrinol.. 149. 141-151 (1999)
Ohe K.:“烟酰胺增强 FRTL-5 细胞中的 TSHR 和 MHC II 类启动子活性”Mol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
後藤 公宣: "前立腺癌治療に用いられる抗アンドロゲン剤のアンドロゲンレセプターに対する作用"Pharma Medica. 17. 97 (1999)
Kiminobu Goto:“前列腺癌治疗中使用的抗雄激素对雄激素受体的影响”Pharma Medica 17. 97 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAYANAGI Ryoichi其他文献
TAKAYANAGI Ryoichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAYANAGI Ryoichi', 18)}}的其他基金
Investigation of the genes associated with bone mineral density by high-density SNP chip analysis in a large cohort study
在大型队列研究中通过高密度 SNP 芯片分析研究与骨矿物质密度相关的基因
- 批准号:
20390264 - 财政年份:2008
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism of glucocorticoid-induced osteoporosis by suppression of Wnt signaling pathway and the development of prediction method at its preclinical stage
阐明糖皮质激素通过抑制Wnt信号通路诱发骨质疏松的机制并开发临床前阶段的预测方法
- 批准号:
17390272 - 财政年份:2005
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Detection system for post-receptor disorders by three-dimensional imaging
三维成像受体后疾病检测系统
- 批准号:
14370330 - 财政年份:2002
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of the processing mechanism of endothelin-converting enzyme and the development of its inhibitors as novel therapeutics for vascular complications.
分析内皮素转换酶的加工机制及其抑制剂作为血管并发症新疗法的开发。
- 批准号:
08671167 - 财政年份:1996
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Purification and structure analysis of endothelin-converting enzyme.
内皮素转换酶的纯化及结构分析。
- 批准号:
04671488 - 财政年份:1992
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
- 批准号:
10647707 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
A co-infection model for papillomavirus associated infections and cancers
乳头瘤病毒相关感染和癌症的共感染模型
- 批准号:
10667710 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Molecular mechanisms underlying optimal glucocorticoid therapy for vocal fold disease
声带疾病最佳糖皮质激素治疗的分子机制
- 批准号:
10647027 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
High-throughput thermodynamic and kinetic measurements for variant effects prediction in a major protein superfamily
用于预测主要蛋白质超家族变异效应的高通量热力学和动力学测量
- 批准号:
10752370 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors
基于活性的调节组分析用于发现共价转录因子抑制剂
- 批准号:
10603503 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别: